Remove Hurdles to Cancer Care

Share

COVID-19 has shone a spotlight on the significant barriers to affordable health care that cancer patients have long faced. While relief packages and proposals to date have worked to address affordability of COVID-specific testing and treatment, policymakers must also tackle hurdles that cancer patients face like removing the red tape of prior authorization and step therapy, reducing out-of-pocket costs, and ensuring cost-sharing assistance directly benefits patients. There has been a great deal of research and investment in effective therapies that allow people fighting cancer to survive and live longer. Cancer patients need Congress to act quickly to remove hurdles to quality care.

56% of cancer patients and survivors are worried about being able to afford their treatment

Latest Updates

November 4, 2024
Massachusetts

S.2971, An Act relative to medically necessary breast screenings and exams for equity and early detection requires that health plans regulated by the Commonwealth cover medically necessary screening and diagnostic breast imaging with no out- of-pocket costs.

September 25, 2024

WASHINGTON, D.C.— Today U.S. Senators Jeanne Shaheen (NH) and Tammy Baldwin (WI) plan to introduce a bill, the Health Care Affordability Act of 2024, that would make permanent the Affordable Care Act (ACA) enhanced tax credits that help make health insurance coverage affordable for an estimated 20 million people.

June 13, 2024

Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, applaud the Supreme Court’s unanimous ruling reversing the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al, on the grounds that the plaintiffs don’t have standing in their challenge concerning the

June 11, 2024
National

The Consumer Financial Protection Bureau (CFPB) released a proposed rule today to lessen the impact of medical debt on an individual’s credit.

Remove Hurdles to Cancer Care Resources

The U.S. spent approximately $183 billion on cancer-related health care in 2015. This represents a signification portion of the total health care spending in the U.S. And it is expected to keep growing. By 2030 cancer-related health care spending is expected to reach nearly $246 billion.

Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer.

ACS CAN submitted comments on the Medicare Part C and D Rule.